Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spotlight on PSMA as a new theranostic biomarker for bladder cancer.
Tumedei MM, Ravaioli S, Matteucci F, Celli M, De Giorgi U, Gunelli R, Puccetti M, Paganelli G, Bravaccini S. Tumedei MM, et al. Among authors: paganelli g. Sci Rep. 2021 May 7;11(1):9777. doi: 10.1038/s41598-021-89160-0. Sci Rep. 2021. PMID: 33963223 Free PMC article.
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
Caroli P, De Giorgi U, Scarpi E, Fantini L, Moretti A, Galassi R, Celli M, Conteduca V, Rossi L, Bianchi E, Paganelli G, Matteucci F. Caroli P, et al. Among authors: paganelli g. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):348-354. doi: 10.1007/s00259-017-3866-2. Epub 2017 Nov 6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29110067 Clinical Trial.
Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.
De Giorgi U, Sansovini M, Severi S, Nicolini S, Monti M, Gurioli G, Foca F, Casadei C, Conteduca V, Celli M, Di Iorio V, Calistri D, Matteucci F, von Eyben FE, Attard G, Paganelli G. De Giorgi U, et al. Among authors: paganelli g. Br J Cancer. 2021 Oct;125(9):1226-1232. doi: 10.1038/s41416-021-01508-5. Epub 2021 Jul 31. Br J Cancer. 2021. PMID: 34333554 Free PMC article. Clinical Trial.
Targeted radioactive therapy for prostate cancer.
De Giorgi U, Conteduca V, Gurioli G, Matteucci F, Paganelli G. De Giorgi U, et al. Among authors: paganelli g. Lancet. 2021 Aug 7;398(10299):487-488. doi: 10.1016/S0140-6736(21)01336-2. Lancet. 2021. PMID: 34364517 No abstract available.
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab.
Palleschi M, Prochowski Iamurri A, Scarpi E, Mariotti M, Maltoni R, Mannozzi F, Barone D, Paganelli G, Casi M, Giampalma E, De Giorgi U, Rocca A. Palleschi M, et al. Among authors: paganelli g. Sci Rep. 2022 Mar 1;12(1):3385. doi: 10.1038/s41598-022-07143-1. Sci Rep. 2022. PMID: 35233007 Free PMC article.
420 results